Zentalis Pharmaceuticals
ZNTL
#8225
Rank
โ‚ฌ0.27 B
Marketcap
3,92ย โ‚ฌ
Share price
-10.68%
Change (1 day)
231.15%
Change (1 year)

Revenue for Zentalis Pharmaceuticals (ZNTL)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of โ‚ฌ64.79 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Zentalis Pharmaceuticals from 2019 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A
2025 N/A-100%
2024 โ‚ฌ64.79 M
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚ฌ0.50 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚ฌ0.19 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA